Table 2:
Key knowledge gaps |
---|
|
1) Perivascular space anatomy
-What is the exact anatomy of perivascular spaces? -Are there anatomical differences between periarterial, periarteriolar, perivenular (including peripostcapillary venule), and perivenous spaces? |
2) Magnetic resonance imaging (MRI)-visible enlarged perivascular space (EPVS) etiopathogenesis
-How do EPVS relate to arteries and/or veins? -What is the temporal evolution of EPVS and why do they become enlarged, i.e., MRI-visible? -How do EPVS relate to perivascular spaces around postcapillary venules where immune cell trafficking occurs? |
3) Fluid dynamics of perivascular spaces
-Is there directional fluid influx along periarterial and outflow along perivenous spaces? -Are fluid dynamics within perivascular spaces disrupted in neuroinflammatory diseases such as multiple sclerosis (MS)? |
4) Neuroinflammatory priming within the perivascular space
-Which cells serve as antigen-presenting cells in the perivascular space, e.g., macrophages, dendritic cells, B cells? -Which mechanisms govern differences between homeostatic immune-cell trafficking within the perivascular space and the trafficking that occurs during a neuroinflammatory outbreak? |
|
Limitations of the available literature |
|
1) Inconsistent terminology
-“Paravascular” versus “perivascular” -Leukocytes “cross the blood-brain barrier” |
2) Insufficient anatomical delineation of the perivascular space/compartment, including insufficient definition of locations within the vascular tree (artery, arteriole, venule, vein) |
3) Unclear translatability of animal study findings
-Caused by anatomical differences, e.g., between human and rodents |